Electrical Impedance Myography in Dogs With Degenerative Myelopathy.
SOD1
atrophy
canine (dog)
degenerative myelopathy
electrical impedance myography (EIM)
neuromuscular
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
02
2022
accepted:
20
04
2022
entrez:
17
6
2022
pubmed:
18
6
2022
medline:
18
6
2022
Statut:
epublish
Résumé
Canine degenerative myelopathy (DM) leads to disuse and neurogenic muscle atrophy. Currently there is a lack of non-invasive quantitative measures of muscle health in dogs with DM. Muscle pathology has been previously quantified in other disorders using the technique of electrical impedance myography (EIM) but it has not been reported for DM. The objective of this study was to compare EIM between DM-affected and similar aged healthy dogs as well as assess EIM changes over time in DM-affected dogs. Multifrequency EIM was performed on DM affected dogs at baseline and during disease progression and on age-matched healthy dogs. Muscles evaluated in the pelvic limbs included the craniotibialis, gastrocnemius, gracilis, sartorius, and biceps femoris. The 100 kHz phase angle was extracted from the full frequency set for analysis. Phase values were lower in DM dogs as compared to healthy controls. Specifically, phase of the gastrocnemius was lower on the left (θ = 7.69, 13.06;
Identifiants
pubmed: 35711791
doi: 10.3389/fvets.2022.874277
pmc: PMC9196121
doi:
Types de publication
Journal Article
Langues
eng
Pagination
874277Informations de copyright
Copyright © 2022 Kowal, Verga, Pandeya, Cochran, Sabol, Rutkove and Coates.
Déclaration de conflit d'intérêts
SR has equity in, and serves a consultant and scientific advisor to Myolex, Inc. and Haystack Diagnostics, companies that design impedance devices for clinical and research use; he is also a member of the company's Board of Directors. The companies also have an option to license patented impedance technology of which SR is named as an inventor. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Am Vet Med Assoc. 1973 Jun 15;162(12):1045-51
pubmed: 4196853
J Neurol Sci. 2012 Jul 15;318(1-2):55-64
pubmed: 22542607
Nat Rev Dis Primers. 2017 Oct 05;3:17071
pubmed: 28980624
J Vet Intern Med. 2021 Jan;35(1):352-362
pubmed: 33350517
Vet Pathol. 2014 May;51(3):591-602
pubmed: 23839236
Neurotherapeutics. 2017 Jan;14(1):107-118
pubmed: 27812921
Muscle Nerve. 2016 Feb;53(2):169-82
pubmed: 26574709
Clin Neurophysiol. 2007 Nov;118(11):2413-8
pubmed: 17897874
Muscle Nerve. 2009 Dec;40(6):936-46
pubmed: 19768754
Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):85-92
pubmed: 26458122
J Vet Intern Med. 2017 Mar;31(2):513-520
pubmed: 28186658
Muscle Nerve. 2015 Oct;52(4):592-7
pubmed: 25702806
Amyotroph Lateral Scler. 2012 Sep;13(5):439-45
pubmed: 22670883
Ann Neurol. 2017 May;81(5):622-632
pubmed: 28076894
BMC Vet Res. 2019 Jun 10;15(1):192
pubmed: 31182094
J Vet Intern Med. 2007 Nov-Dec;21(6):1323-31
pubmed: 18196743
Arch Phys Med Rehabil. 2009 Oct;90(10):1806-10
pubmed: 19801075
Vet Clin North Am Small Anim Pract. 2010 Sep;40(5):929-50
pubmed: 20732599
Muscle Nerve. 2014 Mar;49(3):441-3
pubmed: 24273034
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2794-9
pubmed: 19188595
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):555-561
pubmed: 30265154
PLoS One. 2017 Mar 24;12(3):e0173557
pubmed: 28339469
PLoS One. 2012;7(9):e45004
pubmed: 23028733
J Vet Intern Med. 2006 Jul-Aug;20(4):927-32
pubmed: 16955818
Zoology (Jena). 2016 Feb;119(1):64-73
pubmed: 26432396
Sci Rep. 2016 Sep 02;6:32615
pubmed: 27585740
J Neurosci Res. 2013 Dec;91(12):1639-50
pubmed: 24043596
J Neurosci Res. 2014 Apr;92(4):531-41
pubmed: 24375814